Anti-Human IL13 Therapeutic Antibody (Tralokinumab)
Recombinant monoclonal antibody to IL13. Tralokinumab is a human monoclonal antibody which targets the cytokine interleukin 13, and is designed for the treatment of asthma and inflammatory diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-218 |
| Pricing | Inquiry |
| Host | Human |
| Target | IL13 |
| Species Reactivity | Human |
| Type | IgG4 - lambda |
| Applications | ELISA, FC, IP, FuncS, IF, Neut, ICC |
| Storage | At -20°C for one year. |